Ablation of Tumor Necrosis Factor Is Associated with Decreased Inflammation and Alterations of the Microbiota in a Mouse Model of Inflammatory Bowel Disease
Open accessThe DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Abstract
Inflammatory bowel disease (IBD) is associated with prolonged, excess secretions of Tumor Necrosis Factor (TNF). Many patients with IBD have successful management of IBD symptoms by blocking TNF secretion or signaling. However, some patients are non-responsive to this therapy, eventually become refractory to therapy, or may develop harmful side-effects [corrected]. Alterations in the microbiota that are associated with the lack of TNF could be a contributing cause of this therapeutic insufficiency seen in some patients. Here we use wildtype (WT) and mice lacking Tnf (Tnf-/-) in an acute TNBS colitis model to investigate the role of TNF in colitis and how its presence or absence affects the colonic microbiota. As expected, Tnf-/- had less severe inflammation than WT mice. Microbiome analysis revealed significant Tnf dependent-differences in alpha and beta diversity. There were also notable differences in many species that were also primarily Tnf dependent. Taken together, our data indicates that TNF contributes significantly to the inflammation and microbiotal alterations in that occur in IBD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Unravelling the pathogenesis of inflammatory bowel disease
Xavier, R. J., & Podolsky, D. K. (2007) · Nature · doi:10.1038/nature06005 · Cited by 4,364
Gut microbiota composition correlates with diet and health in the elderly
Claesson, M. J., Jeffery, I. B., Conde, S., Power, S. E., O’Connor, E. M., Cusack, S., Harris, H. M. B., Coakley, M., Lakshminarayanan, B., O’Sullivan, O., et al. (2012) · Nature · doi:10.1038/nature11319 · Cited by 3,314 · cited 1×
“Many studies have indicated that the gut microbiota plays an active and integral role in maintaining host health [15,16].”
BackgroundDistance‐Based Tests for Homogeneity of Multivariate Dispersions
Anderson, M. J. (2006) · Biometrics · doi:10.1111/j.1541-0420.2005.00440.x · Cited by 3,304
Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment
Morgan, X. C., Tickle, T. L., Sokol, H., Gevers, D., Devaney, K. L., Ward, D. V., Reyes, J. A., Shah, S. A., LeLeiko, N., Snapper, S. B., et al. (2012) · Genome Biology · doi:10.1186/gb-2012-13-9-r79 · Cited by 2,713
Human nutrition, the gut microbiome and the immune system
Kau, A. L., Ahern, P. P., Griffin, N. W., Goodman, A. L., & Gordon, J. I. (2011) · Nature · doi:10.1038/nature10213 · Cited by 2,588
The inner of the two Muc2 mucin-dependent mucus layers in colon is devoid of bacteria
Johansson, M. E. V., Phillipson, M., Petersson, J., Velcich, A., Holm, L., & Hansson, G. C. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0803124105 · Cited by 2,200 · cited 1×
“The mucin layer covering the intestinal epithelia is the first line of defense in preventing the attachment and invasion of luminal bacteria to the intestinal epithelia [6,7].”
BackgroundPANDAseq: paired-end assembler for Illumina sequences
Masella, A. P., Bartram, A. K., Truszkowski, J. M., Brown, D. G., & Neufeld, J. D. (2012) · BMC Bioinformatics · doi:10.1186/1471-2105-13-31 · Cited by 2,132
The Microbiome in Inflammatory Bowel Disease: Current Status and the Future Ahead
Kostic, A. D., Xavier, R. J., & Gevers, D. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.02.009 · Cited by 1,789 · cited 2×
“Other studies have found a decrease in alpha diversity associated with IBD in people [24] but a10-day acute study may not be sufficient to see a statistically significant change in alpha diversity.”
BackgroundDominant and diet-responsive groups of bacteria within the human colonic microbiota
Walker, A. W., Ince, J., Duncan, S. H., Webster, L. M., Holtrop, G., Ze, X., Brown, D., Stares, M. D., Scott, P., Bergerat, A., et al. (2011) · The ISME Journal · doi:10.1038/ismej.2010.118 · Cited by 1,632
Chemically induced mouse models of intestinal inflammation
Wirtz, S., Neufert, C., Weigmann, B., & Neurath, M. F. (2007) · Nature Protocols · doi:10.1038/nprot.2007.41 · Cited by 1,567
Research works printed but not linked: 51
- B Khor, 2011, Genetics and pathogenesis of inflammatory bowel disease, Nature, 474, 307, 10.1038/nature10209 · DOI · Paper page
- RS Blumberg, 2009, Inflammation in the intestinal tract: pathogenesis and treatment, Dig Dis, 27, 455, 10.1159/000235851 · DOI
- DK Podolsky, 2002, Inflammatory bowel disease, N Engl J Med, 347, 417, 10.1056/NEJMra020831 · DOI · Paper page
- K Matsuo, 1997, Histochemistry of the surface mucous gel layer of the human colon, Gut, 40, 782, 10.1136/gut.40.6.782 · DOI · Paper page
- YH Sheng, 2012, Mucins in inflammatory bowel diseases and colorectal cancer, J Gastroenterol Hepatol, 27, 28, 10.1111/j.1440-1746.2011.06909.x · DOI · Paper page
- LW Peterson, 2014, Intestinal epithelial cells: regulators of barrier function and immune homeostasis, Nat Rev Immunol, 14, 141, 10.1038/nri3608 · DOI · Paper page
- S Ardizzone, 2005, Biologic therapy for inflammatory bowel disease, Drugs, 65, 2253, 10.2165/00003495-200565160-00002 · DOI · Paper page
- ZJ Liu, 2009, Potential role of Th17 cells in the pathogenesis of inflammatory bowel disease, World J Gastroenterol, 15, 5784, 10.3748/wjg.15.5784 · DOI · Paper page
- I Monteleone, 2009, Interleukin-23 and Th17 cells in the control of gut inflammation, Mediators Inflamm, 2009, 297645, 10.1155/2009/297645 · DOI · Paper page
- MF Neurath, 2014, New targets for mucosal healing and therapy in inflammatory bowel diseases, Mucosal Immunol, 7, 6, 10.1038/mi.2013.73 · DOI · Paper page
- K Li, 2012, Analyses of the microbial diversity across the human microbiome, PLoS ONE, 7, e32118, 10.1371/journal.pone.0032118 · DOI · Paper page
- FD Bushman, 2013, Diet, the human gut microbiota, and IBD, Anaerobe, 30, 00052
- V Leone, 2013, Diet, microbes, and host genetics: the perfect storm in inflammatory bowel diseases, J Gastroenterol, 48, 315, 10.1007/s00535-013-0777-2 · DOI · Paper page
- J Bien, 2013, The intestinal microbiota dysbiosis and Clostridium difficile infection: is there a relationship with inflammatory bowel disease?, Therap Adv Gastroenterol, 6, 53, 10.1177/1756283X12454590 · DOI · Paper page
- S Sha, 2013, The biodiversity and composition of the dominant fecal microbiota in patients with inflammatory bowel disease, Diagn Microbiol Infect Dis, 75, 245, 10.1016/j.diagmicrobio.2012.11.022 · DOI · Paper page
- S Oliva, 2012, Randomised clinical trial: the effectiveness of Lactobacillus reuteri ATCC 55730 rectal enema in children with active distal ulcerative colitis, Aliment Pharmacol Ther, 35, 327, 10.1111/j.1365-2036.2011.04939.x · DOI · Paper page
- E Papa, 2012, Non-invasive mapping of the gastrointestinal microbiota identifies children with inflammatory bowel disease, PLoS ONE, 7, e39242, 10.1371/journal.pone.0039242 · DOI · Paper page
- CP Braegger, 1992, Tumour necrosis factor alpha in stool as a marker of intestinal inflammation, Lancet, 339, 89, 10.1016/0140-6736(92)90999-J · DOI · Paper page
- H Masuda, 1995, Expression of IL-8, TNF-alpha and IFN-gamma m-RNA in ulcerative colitis, particularly in patients with inactive phase, J Clin Lab Immunol, 46, 111
- SJ van Deventer, 1997, Review article: Chemokine production by intestinal epithelial cells: a therapeutic target in inflammatory bowel disease?, Aliment Pharmacol Ther, 3, 116, 10.1111/j.1365-2036.1997.tb00816.x · doi:10.1111/j.1365-2036.1997.tb00816.x
- C Thukral, 2005, The Role of Antibiotics in Inflammatory Bowel Disease, Curr Treat Options Gastroenterol, 8, 223, 10.1007/s11938-005-0014-z · DOI
- BG Feagan, 2001, Infliximab for the treatment of Crohn#x2019;s disease: efficacy, safety and pharmacoeconomics, Can J Clin Pharmacol, 8, 188
- JR Curtis, 2007, Risk of serious bacterial infections among rheumatoid arthritis patients exposed to tumor necrosis factor alpha antagonists, Arthritis Rheum, 56, 1125, 10.1002/art.22504 · DOI · Paper page
- JF Colombel, 2004, The safety profile of infliximab in patients with Crohn#x2019;s disease: the Mayo clinic experience in 500 patients, Gastroenterology, 126, 19, 10.1053/j.gastro.2003.10.047 · DOI · Paper page
- VV Jain, 2006, Reactivation histoplasmosis after treatment with anti-tumor necrosis factor alpha in a patient from a nonendemic area, Respir Med, 100, 1291, 10.1016/j.rmed.2005.09.020 · doi:10.1016/j.rmed.2005.09.020
- KL Wood, 2003, Histoplasmosis after treatment with anti-tumor necrosis factor—alpha therapy, Am J Respir Crit Care Med, 167, 1279, 10.1164/rccm.200206-563OC · DOI · Paper page
- C Abreu, 2013, Tuberculosis in anti-TNF-alpha treated patients remains a problem in countries with an intermediate incidence: Analysis of 25 patients matched with a control population, J Crohns Colitis, 10, 00108
- M Neurath, 2000, TNBS-colitis, Int Rev Immunol, 19, 51, 10.3109/08830180009048389 · DOI · Paper page
- W Strober, 2002, The immunology of mucosal models of inflammation, Annu Rev Immunol, 20, 495, 10.1146/annurev.immunol.20.100301.064816 · DOI · Paper page
- M Pasparakis, 1996, Immune and inflammatory responses in TNF alpha-deficient mice: a critical requirement for TNF alpha in the formation of primary B cell follicles, follicular dendritic cell networks and germinal centers, and in the maturation of the humoral immune response, J Exp Med, 184, 1397, 10.1084/jem.184.4.1397 · DOI · Paper page
- Y Naito, 2003, Enhanced intestinal inflammation induced by dextran sulfate sodium in tumor necrosis factor—alpha deficient mice, J Gastroenterol Hepatol, 18, 560, 10.1046/j.1440-1746.2003.03034.x · DOI · Paper page
- ZZ Liu, 2008, Accurate taxonomy assignments from 16S rRNA sequences produced by highly parallel pyrosequencers, Nucleic Acids Res, 36, e120, 10.1093/nar/gkn491 · DOI · Paper page
- CW Nossa, 2010, Design of 16S rRNA gene primers for 454 pyrosequencing of the human foregut microbiome, World J Gastroenterol, 16, 4135, 10.3748/wjg.v16.i33.4135 · DOI · Paper page
- JG Caporaso, 2010, QIIME allows analysis of high-throughput community sequencing data, Nat Meth, 7, 335, 10.1038/nmeth.f.303 · DOI · Paper page
- D McDonald, 2012, An improved Greengenes taxonomy with explicit ranks for ecological and evolutionary analyses of bacteria and archaea, ISME J, 6, 610, 10.1038/ismej.2011.139 · DOI · Paper page
- M Hamady, 2010, Fast UniFrac: facilitating high-throughput phylogenetic analyses of microbial communities including analysis of pyrosequencing and PhyloChip data, ISME J, 4, 17, 10.1038/ismej.2009.97 · DOI · Paper page
- M Anderson, 2001, A new method for non-parametric multivariate analysis of variance, Austral Ecology, 26, 32
- CJF ter Braak, 1986, Canonical correspondence analysis: A new eigenvector technique for multivariate direct gradient analysis, Ecology, 67, 1167, 10.2307/1938672 · DOI · Paper page
- H Tuomisto, 2010, A diversity of beta diversities: straightening up a concept gone awry. Part 1. Defining beta diversity as a function of alpha and gamma diversity, Ecography, 33, 2, 10.1111/j.1600-0587.2009.05880.x · DOI · Paper page
- M Noti, 2010, TNF suppresses acute intestinal inflammation by inducing local glucocorticoid synthesis, J Exp Med, 207, 1057, 10.1084/jem.20090849 · DOI · Paper page
- MF Neurath, 1997, Predominant pathogenic role of tumor necrosis factor in experimental colitis in mice, Eur J Immunol, 27, 1743, 10.1002/eji.1830270722 · DOI · Paper page
- C Shen, 2007, Remission-inducing effect of anti-TNF monoclonal antibody in TNBS colitis: Mechanisms beyond neutralization?, Inflamm Bowel Dis, 13, 308, 10.1002/ibd.20005 · DOI
- W Fries, 2008, Infliximab and etanercept are equally effective in reducing enterocyte apoptosis in experimental colitis, Int J Med Sci, 5, 169, 10.7150/ijms.5.169 · DOI
- S Zeissig, 2004, Downregulation of epithelial apoptosis and barrier repair in active Crohn#x2019;s disease by tumour necrosis factor alpha antibody treatment, Gut, 53, 1295, 10.1136/gut.2003.036632 · DOI · Paper page
- W Qiu, 2011, PUMA-mediated intestinal epithelial apoptosis contributes to ulcerative colitis in humans and mice, J Clin Invest, 121, 1722, 10.1172/JCI42917 · DOI · Paper page
- M Iizuka, 2011, Wound healing of intestinal epithelial cells, World J Gastroenterol, 17, 2161, 10.3748/wjg.v17.i17.2161 · DOI · Paper page
- MG Rooks, 2014, Gut microbiome composition and function in experimental colitis during active disease and treatment-induced remission, ISME J, 8, 1403, 10.1038/ismej.2014.3 · DOI · Paper page
- LL Presley, 2010, Bacteria associated with immunoregulatory cells in mice, Appl Environ Microbiol, 76, 936, 10.1128/AEM.01561-09 · DOI · Paper page
- PP Bosshard, 2002, Turicibacter sanguinis gen. nov., sp. nov., a novel anaerobic, Gram-positive bacterium, Int J Syst Evol Microbiol, 52, 1263, 10.1099/00207713-52-4-1263 · DOI · Paper page
- MG Rooks, 2014, Gut microbiome composition and function in experimental colitis during active disease and treatment-induced remission, ISME J, 8, 1403, 10.1038/ismej.2014.3 · DOI · Paper page
- J Sarowska, 2013, The therapeutic effect of probiotic bacteria on gastrointestinal diseases, Adv Clin Exp Med, 22, 759
Cited by
Microbial network disturbances in relapsing refractory Crohn’s disease
Swiss IBD Cohort Investigators, Yilmaz, B., Juillerat, P., Øyås, O., Ramon, C., Bravo, F. D., Franc, Y., Fournier, N., Michetti, P., Mueller, C., et al. (2019) · Nature Medicine · doi:10.1038/s41591-018-0308-z · Cited by 428
Ma, S., Shungin, D., Mallick, H., Schirmer, M., Nguyen, L. H., Kolde, R., Franzosa, E., Vlamakis, H., Xavier, R., & Huttenhower, C. (2022) · Genome biology · doi:10.1186/s13059-022-02753-4 · Cited by 164
Bartley, A., Yang, T., Arocha, R., Malphurs, W. L., Larkin, R., Magee, K. L., Vickroy, T. W., & Zubcevic, J. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.01593 · Cited by 44
“Both cytokines have previously linked to proinflammatory responses in the gut and subsequent shifts in the microbiota diversity (Rosser et al., 2014; Jones-Hall et al., 2015; Burton et al., 2017).”
BackgroundTherapeutic Potentials of Microalgae and Their Bioactive Compounds on Diabetes Mellitus
Tamel Selvan, K., Goon, J. A., Makpol, S., & Tan, J. K. (2023) · Marine Drugs · doi:10.3390/md21090462 · Cited by 32
Metadata
- Authors
- Jones-Hall, Y. L., Kozik, A., & Nakatsu, C.
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2015-03-16
- Volume
- 10
- Issue
- 3
- Pages
- e0119441
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W2091256633
- Cited by
- 81
- References
- 15
- FWCI
- 4.73
- Type
- journal article
- Language
- en
- Update notices
- correction (2015-04-10)
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Ablation of Tumor Necrosis Factor Is Associated with Decreased Inflammation and Alterations of the Microbiota in a Mouse Model of Inflammatory Bowel Disease. https://app.cochat.ai/papers/10.1371/journal.pone.0119441
- The paper
- Jones-Hall, Y. L., Kozik, A., & Nakatsu, C. (2015). Ablation of Tumor Necrosis Factor Is Associated with Decreased Inflammation and Alterations of the Microbiota in a Mouse Model of Inflammatory Bowel Disease. PLOS ONE. https://doi.org/10.1371/journal.pone.0119441
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.